Drugs / Kunamin
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05417997 | May → Dec 2021 | COVID-19, bacterial pneumonia, influenza | RAAS Nutritionals, LLC | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Kunamin | “Kunamin® 20 capsules 500mg daily plus; Standard therapy interventions determined and prescribed by investigators including:” NCT05417997 ↗ |